Scholars Central

Conference abstract

Nanoscale liposomal CD22and#916;E12-siRNA formulation as a potent RNAi therapeutic against B-cell precursor acute lymphoblastic leukemia

Authors: Fatih M Uckun

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

B-cell precursor acute lymphoblastic leukemia (BPL) is the most common form of cancer in children and adolescents. CD22ΔE12 has recently been identified as a characteristic genetic defect of therapy-refractory clones in relapsed pediatric BPL. A nanoscale liposomal formulation of CD22ΔE12 siRNA using the standard thin film evaporation method and a mixture of the cationic lipid 2,3-dioleoyloxypropyltrimethylammonium chloride (DOTAP) for complexation with the polyanionic siRNA cargo as well as cell membrane penetration and the helper neutral lipid 1,2-dioleoyl-sn-glcero-3-phosphoethanolamine (DOPE) as a membrane phase inversion inducer capable of facilitating endosomal escape of the internalized siRNA molecules. This nanoformulation caused effective CD22ΔE12 depletion in BPL cells and abrogated their clonogenicity. CD22ΔE12-siRNA LNF also abrogated the in vivo clonogenicity of the leukemia-initiating leukemic cell fraction in recently reported xenograft specimens derived from patients with BPL and exhibited potent in vivo anti-leukemic activity in NOD/SCID mouse xenograft models of aggressive BPL.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Nanomedicine & Nanotechnology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Nanomedicine & Nanotechnology
  • SubjectNanotechnology
  • BylineArticles whose byline prints “Fatih M Uckun”